In contrast, nuclear expression of Survivin showed no significant difference between primary and secondary GBMs (P=0.51), that is, the rate of nuclear positive staining of Survivin in the primary GBMs was 73% (22 out of 30), and in the secondary GBM group, 81% (21 out of 26). The gene discussed is BIRC5; the disease is glioblastoma.